Invention Grant
- Patent Title: Claudin-18.2-specific immunoreceptors and T cell epitopes
-
Application No.: US15572919Application Date: 2016-05-09
-
Publication No.: US11713346B2Publication Date: 2023-08-01
- Inventor: Ugur Sahin , Ozlem Tureci , Petra Oehm , Tana Omokoko , Andrea Breitkreuz , Karolina Anna Mroz , Lisa Hebich
- Applicant: BioNTech Cell & Gene Therapies GmbH , TRON—Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-Universität Mainz Gemein-Nutzige GMBH
- Applicant Address: DE Mainz
- Assignee: BioNTech Cell & Gene Therapies GmbH,TRON—Translationale Onkologie An Der Universitätsmedizin der Johannes Gutenberg-Universität Mainz Gemeinnützige GmbH
- Current Assignee: BioNTech Cell & Gene Therapies GmbH,TRON—Translationale Onkologie An Der Universitätsmedizin der Johannes Gutenberg-Universität Mainz Gemeinnützige GmbH
- Current Assignee Address: DE Mainz; DE Mainz
- Agency: Neal, Gerber & Eisenberg LLP
- Priority: WO TEP2015060357 2015.05.11
- International Application: PCT/EP2016/060337 2016.05.09
- International Announcement: WO2016/180782A 2016.11.17
- Date entered country: 2017-11-09
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C07K14/725 ; C07K7/06 ; A61K39/00 ; C07K14/705 ; C07K14/74
Abstract:
The present invention provides Claudin-18.2-specific immunoreceptors (T cell receptors and artificial T cell receptors (chimeric antigen receptors; CARs)) and T cell epitopes which are useful for immunotherapy.
Public/Granted literature
- US20180282389A1 CLAUDIN-18.2-SPECIFIC IMMUNORECEPTORS AND T CELL EPITOPES Public/Granted day:2018-10-04
Information query
